The balance sheet strengthened with a $1.0B equity raise, reducing debt-to-equity from 0.55 in 2024Q1 to 0.13 in 2026Q2, while cash of $1.1B covers total debt of $238.5M by 4.6 times.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 1.66B | 1.5B | 1.38B | 1.26B | 1.21B | 1.09B | 862.66M | 523.17M | 240.52M | 180.63M | 174.12M | 250.73M | 106.48M | 49.11M | 9.01M |
| Cash & Short-Term Investments | 1.09B | 1.08B | 968.28M | 878.98M | 898.39M | 914.28M | 737.27M | 440.99M | 153.87M | 118.87M | 146.12M | 230.53M | 87.18M | 30.5M | 5.76M |
| Cash Only | 1.09B | 1.08B | 945.59M | 642.1M | 466.09M | 84.39M | 48.67M | 61.93M | 46.41M | 12.62M | 15.26M | 28.95M | 87.18M | 30.5M | 5.76M |
| Short-Term Investments | 0 | 0 | 22.69M | 236.88M | 432.3M | 829.9M | 688.61M | 379.06M | 107.46M | 106.25M | 130.86M | 201.59M | 0 | 0 | 0 |
| Accounts Receivable | 421.97M | 296.53M | 314.17M | 278.29M | 244.38M | 122.07M | 78.56M | 53.35M | 62.22M | 44.09M | 13.4M | 5.86M | 5.94M | 6.63M | 1.31M |
| Days Sales Outstanding | 47.95 | 46.93 | 67.58 | 93.83 | 108.75 | 71.24 | 73.34 | 64.41 | 88.15 | 76.29 | 22.52 | 11.24 | 13.62 | 43.88 | 33.61 |
| Inventory | 80.35M | 68.44M | 44.74M | 40.76M | 35.41M | 26.91M | 20.03M | 12.39M | 13.63M | 9M | 6.41M | 8.09M | 11.54M | 10.65M | 1.6M |
| Days Inventory Outstanding | 27.61 | 30.82 | 24.24 | 25.22 | 28.32 | 30.85 | 35.91 | 25.78 | 29.97 | 23.53 | 17.27 | 26.18 | 53.74 | 104.31 | 52.3 |
| Other Current Assets | 65.13M | 55.83M | 48.63M | 60.52M | 33.63M | 228K | 187K | 55K | 4.6M | 59K | 1.09M | 901K | 503K | 150K | 340K |
| Total Non-Current Assets | 998.55M | 1.01B | 284.92M | 183.15M | 182.66M | 143.35M | 69.49M | 59.49M | 27.65M | 33.99M | 36.56M | 14.51M | 17.15M | 10.62M | 4.28M |
| Property, Plant & Equipment | 447.25M | 349.73M | 248.19M | 167.75M | 164.33M | 124.53M | 54.75M | 47.01M | 24.34M | 29.67M | 32.29M | 12.71M | 14.57M | 9.79M | 4.07M |
| Fixed Asset Turnover | 7.20x | 6.59x | 6.84x | 6.45x | 4.99x | 5.02x | 7.14x | 6.43x | 10.59x | 7.11x | 6.72x | 14.98x | 10.93x | 5.63x | 3.50x |
| Goodwill | 141.1M | 141.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 360.2M | 373.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 207K |
| Other Non-Current Assets | 49.99M | 36.9M | 36.72M | 15.4M | 18.33M | 18.82M | 14.74M | 12.48M | 3.32M | 4.32M | 4.28M | 1.8M | 2.57M | 825K | -1 |
| Total Assets | 2.66B | 2.51B | 1.66B | 1.44B | 1.39B | 1.24B | 932.15M | 582.66M | 268.17M | 214.61M | 210.68M | 265.24M | 123.62M | 59.72M | 13.29M |
| Asset Turnover | 1.13x | 0.92x | 1.02x | 0.75x | 0.59x | 0.51x | 0.42x | 0.52x | 0.96x | 0.98x | 1.03x | 0.72x | 1.29x | 0.92x | 1.07x |
| Asset Growth % | 167.67% | 51.02% | 15.19% | 3.39% | 12.78% | 32.65% | 59.98% | 117.27% | 24.96% | 1.87% | -20.57% | 114.56% | 106.99% | 349.28% | - |
| Total Current Liabilities | 553.2M | 441.23M | 344.05M | 307.27M | 310.5M | 218.96M | 199.05M | 179.87M | 113.98M | 105.56M | 96.42M | 80.47M | 29.87M | 23.57M | 138.9M |
| Accounts Payable | 75.15M | 33.16M | 34.92M | 15M | 31.15M | 27.21M | 8.1M | 8.6M | 14.59M | 8.53M | 11.48M | 7.33M | 8.87M | 11.3M | 4.5M |
| Days Payables Outstanding | 21.1 | 14.93 | 18.92 | 9.28 | 24.92 | 31.19 | 14.51 | 17.9 | 32.06 | 22.3 | 30.9 | 23.72 | 41.28 | 110.62 | 147.41 |
| Short-Term Debt | 80.29M | 80.32M | 80.36M | 80.4M | 80.35M | 50.05M | 50.05M | 50.12M | 50.15M | 50.11M | 49.62M | 42.09M | 2.34M | 1.84M | 131.75M |
| Deferred Revenue (Current) | 124.11M | 24.91M | 19.75M | 16.61M | 10.78M | 7.4M | 50.13M | 56.02M | 4.13M | 1.42M | 574K | 144K | 112K | 970K | 314K |
| Other Current Liabilities | 22.82M | 102.11M | 73.39M | 69.1M | 62.96M | 58.15M | 47.74M | 25.5M | 22.68M | 19.04M | 22.39M | 12.24M | 8.31M | 3.71M | 952K |
| Current Ratio | 3.00x | 3.39x | 4.00x | 4.10x | 3.90x | 4.99x | 4.33x | 2.91x | 2.11x | 1.71x | 1.81x | 3.12x | 3.56x | 2.08x | 0.06x |
| Quick Ratio | 2.85x | 3.24x | 3.87x | 3.96x | 3.79x | 4.87x | 4.23x | 2.84x | 1.99x | 1.63x | 1.74x | 3.02x | 3.18x | 1.63x | 0.05x |
| Cash Conversion Cycle | 54.45 | 62.82 | 72.9 | 109.77 | 112.16 | 70.9 | 94.73 | 72.29 | 86.05 | 77.52 | 8.89 | 13.7 | 26.07 | 37.56 | -61.51 |
| Total Non-Current Liabilities | 282.8M | 354.4M | 121.27M | 369.1M | 378.23M | 364.23M | 246.86M | 124.07M | 122.03M | 83.64M | 7.79M | 0 | 265.09M | 207.66M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 282.94M | 281.65M | 280.39M | 202.49M | 73.66M | 73.36M | 73.06M | 0 | 0 | 24.47M | 22.46M | 0 |
| Capital Lease Obligations | 510.88M | 118.47M | 96.59M | 67.03M | 76.58M | 61.04M | 21.25M | 26.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 111.8M | 110.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 122.95M | 108.47M | 7.84M | 0 | 0 | 1.48M | 320K | 310K | 8.61M | 10.57M | 7.79M | 0 | 240.61M | 185.2M | 0 |
| Total Liabilities | 836M | 795.62M | 465.31M | 676.37M | 688.73M | 583.18M | 445.92M | 303.94M | 236.01M | 189.2M | 104.2M | 80.47M | 294.96M | 231.23M | 138.9M |
| Total Debt | 223.37M | 214.38M | 187.12M | 441.99M | 446.22M | 397.23M | 281.09M | 155.81M | 123.51M | 123.18M | 49.62M | 42.09M | 26.81M | 24.31M | 131.75M |
| Net Debt | -868.14M | -861.76M | -758.47M | -200.1M | -19.87M | 312.85M | 232.43M | 93.89M | 77.1M | 110.56M | 34.37M | 13.14M | -60.36M | -6.19M | 125.99M |
| Debt / Equity | 0.12x | 0.13x | 0.16x | 0.58x | 0.63x | 0.61x | 0.58x | 0.56x | 3.84x | 4.85x | 0.47x | 0.23x | - | - | - |
| Debt / EBITDA | -0.95x | - | - | - | - | - | - | - | - | - | - | - | 4.61x | - | - |
| Net Debt / EBITDA | 3.68x | - | - | - | - | - | - | - | - | - | - | - | -10.38x | - | - |
| Interest Coverage | -24.51x | -64.89x | -16.76x | -33.38x | -57.68x | -55.72x | -14.23x | -10.49x | -10.94x | -31.56x | -186.96x | -19.05x | 0.16x | -2.11x | - |
| Total Equity | 1.82B | 1.71B | 1.2B | 765.33M | 705.74M | 653.3M | 486.24M | 278.71M | 32.16M | 25.42M | 106.48M | 184.76M | -171.34M | -171.51M | -125.61M |
| Equity Growth % | 175.05% | 43.25% | 56.2% | 8.44% | 8.03% | 34.36% | 74.46% | 766.58% | 26.54% | -76.13% | -42.37% | 207.84% | 0.1% | -36.54% | - |
| Book Value per Share | 12.71 | 12.52 | 9.58 | 6.66 | 7.17 | 7.21 | 6.00 | 4.01 | 0.56 | 0.47 | 2.06 | 3.87 | -4.67 | -4.68 | -40.18 |
| Total Shareholders' Equity | 1.82B | 1.71B | 1.2B | 765.33M | 705.74M | 653.3M | 486.24M | 278.71M | 32.16M | 25.42M | 106.48M | 184.76M | -171.34M | -171.51M | -125.61M |
| Common Stock | 14K | 14K | 12K | 11K | 11K | 10K | 9K | 8K | 7K | 6K | 5K | 5K | 1K | 1K | 1K |
| Retained Earnings | -2.93B | -2.78B | -2.57B | -2.38B | -1.94B | -1.39B | -929.32M | -699.17M | -574.53M | -446.38M | -345.85M | -250.08M | -179.81M | -174.66M | -137.55M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -108K | -258K | -344K | -3.08M | -16.36M | -2.29M | 4.26M | 919K | -552K | -766K | -725K | -1.42M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Persistent negative operating margins
Total assets grew 80% from $1.5B in 2024Q1 to $2.7B in 2026Q2, driven by a $1.0B equity raise in late 2025, as reported in financial statements, while liabilities rose only 24%.
The balance sheet has expanded rapidly, but the composition reveals a strategic shift: equity surged from $794M to $1.8B, while total debt was reduced from $440M to $238M. This deleveraging, combined with a growing cash pile, suggests management prioritized financial flexibility over maximizing returns on equity. The trajectory indicates a deliberate move to fund growth without relying on debt markets, which is prudent given the company's ongoing operating losses.
Debt-to-equity fell from 0.55 in 2024Q1 to 0.13 in 2026Q2, with total debt down to $238.5M, per reported figures, while cash of $1.1B covers debt over 4.6 times.
The dramatic reduction in leverage appears strategic, likely funded by the equity raise, and positions the company to withstand operational volatility. With a current ratio of 3.0 and minimal debt maturities, refinancing risk is low. However, the low leverage also implies a conservative capital structure that may dilute returns if growth stalls, but it provides a cushion against the persistent negative operating margins.
PP&E nearly doubled from $180M in 2024Q1 to $447M in 2026Q2, while goodwill emerged at $141M in 2025Q4, as per balance sheet data, indicating investment in lab capacity and an acquisition.
The sharp increase in PP&E reflects significant capital expenditure on laboratory automation and capacity, aligning with the reported capex spike in 2026Q2. The appearance of goodwill suggests an acquisition, which introduces potential impairment risk if growth expectations are not met. The asset mix is becoming more asset-heavy, which could pressure margins if utilization does not scale, but it also signals a commitment to long-term operational capacity.
Equity jumped from $794M to $1.8B over ten quarters, driven by a $1.0B capital raise, while retained earnings remained deeply negative at -$2.9B, as reported in financial statements.
The equity expansion is primarily from external financing, not retained earnings, which remain deeply negative due to cumulative losses. This suggests the company is relying on shareholder capital to fund operations, and the dilution from the raise may pressure future EPS. However, the strong cash position provides a runway to achieve profitability without immediate financing needs, though the negative retained earnings highlight the long road to book value accretion.
Cash and equivalents stood at $1.1B in 2026Q2, up from $814M in 2024Q1, with a current ratio of 3.0, per balance sheet data, providing a multi-year runway against operating losses.
The liquidity position is robust, with cash covering over four times total debt and a current ratio well above 1.0. Given the TTM net loss of approximately -$67M per quarter, the cash pile appears sufficient to fund operations for several years without external financing. This buffer is critical as the company continues to invest heavily in growth, but investors should monitor the burn rate relative to cash, especially if revenue growth decelerates.
Goodwill of $141M appeared in 2025Q4, and stock-based compensation of $103M in 2026Q2 exceeds operating cash flow, as per reported figures, suggesting potential overstatement of asset quality and cash generation.
The sudden appearance of goodwill indicates an acquisition that may carry impairment risk if the acquired business underperforms. Additionally, the heavy use of stock-based compensation, which is non-cash but dilutive, inflates equity and masks the true economic cost of operations. Investors should adjust for SBC to assess the real cash burn and the sustainability of the balance sheet strength, as the reported equity may overstate the company's intrinsic value.
Quick answers to the most common questions about buying NTRA stock.
As of 2025, Natera, Inc. (NTRA) had total assets of $2.51B including $1.50B in current assets.
Natera, Inc. (NTRA) carries total debt of $214.4M, offset by $1.08B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Natera, Inc. (NTRA) has total shareholders' equity (book value) of $1.71B ($12.52 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Natera, Inc. (NTRA) reported a current ratio of 3.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.